6533b861fe1ef96bd12c564f

RESEARCH PRODUCT

Targeting tumor-initiating cells and compensatory YAP pathway to overcome sorafenib resistance in hepatocellular carcinoma

Ma WörnsPeter R. GalleArndt WeinmannJens U. MarquardtF KeggenhoffS PereiraSnorri S. ThorgeirssonStefanie Heilmann-heimbachCarolin CzaudernaD CastvenJ SchmittTobias KeckKai BreuhahnD BeckerJ HajdukV ShahHarald Binder

subject

business.industryHepatocellular carcinomaCancer researchMedicinebusinessmedicine.diseaseTumor Initiating CellsSorafenib resistancehttps://doi.org/10.1055/s-0041-1733608